Past and Future Methods for Controlling Echinococcus Granulosus in South America

The various Countries of South America (Peru, Brazil, Chile, Uruguay, Argentina) all haveproblems with Echinococcus granulosus s.l in humans. Control of the disease in dogs and grazinganimals began in Uruguay in 1879, and continues in all countries from various beginnings until2022. Our objective is to describe the new vaccine to prevent grazing animals from acquiringE.granulosus s.l., and to predict the possible high degree of control using the addition of thevaccine to the normal control procedures even when programmes address many practicaldifficulties.The recombinant vaccine was used under field conditions using the same protocol in sheep,goats and llamas older than 2 months and up to 6 years: Two injections, one month apartand annual booster. The baseline and the final evaluation were carried out by necropsy incontrol programmes included in Argentina (Chubut, 2007-2013; Río Negro 2009-2017) and inChile (Alto Biobio, 2016-2020; Aysen 2020-2022).Elimination of echinococcosis have been successful only in insular countries. In consequence, tovalidate a model supporting the One Health approach that might be reproducible successfullyin different regions of South America is required. Including the socio-cultural understandingand the environmental context is mandatory to optimize the use of the vaccine under theseoperational conditions.The EG95 vaccine, made in Argentina, has been tested, and continues to be tested, inArgentina and Chile, and more recently in Peru. Furthermore, the vaccine, now available,is being made in large quantities in Argentina and China, and appears to be an additionalcontrol technology that may allow elimination of E.granulosus s.l. from South America. Thebest control strategies appear to be dog treatments and regular vaccination of sheep andgoats for 10 years until all old sheep have been removed. If dogs or grazing animals enterfrom outside the controlled environment, treatments will need to be continued. The vaccinealso seems to reduce E.granulosus s.l. cysts reaching infectivity for dogs, and has some effectagainst Fasciola hepatica.Fil: Poggio, Thelma Veronica. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Ciencia y Tecnología "Dr. César Milstein". Fundación Pablo Cassará. Instituto de Ciencia y Tecnología "Dr. César Milstein"; ArgentinaFil: Jensen, Oscar. Centro de Investigacion En Zoonosis; ArgentinaFil: Chacon Saravia, Tomas. Ministerio de Agricultura, Ganadería, Pesca y Alimento. Servicio Nacional de Sanidad y Calidad Agroalimentaria; ArgentinaFil: Pino Nuñez, Alejandro. No especifíca;Fil: Boado, Lorena Analía. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Ciencia y Tecnología "Dr. César Milstein". Fundación Pablo Cassará. Instituto de Ciencia y Tecnología "Dr. César Milstein"; ArgentinaFil: Gomez, Jose Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Ciencia y Tecnología "Dr. César Milstein". Fundación Pablo Cassará. Instituto de Ciencia y Tecnología "Dr. César Milstein"; ArgentinaFil: Heath, David. No especifíca

Promoción de la salud y entornos saludables

A forestar forestalAplicación de un programa educativo participativo en salud  bucal a una comunidad de adultos mayoresBiblioteca móvil y su implementación en el hospital Padre HurtadoConsumo de riesgo de alcohol en Chile: una propuesta innovadora de intervenciónDiseño de un programa interactivo de promoción de la salud vocal para NB1Encuentro formativo en promoción de salud y gestión de entornos saludables para TenoExperiencia docente: programa intersectorial de promoción/prevención en preescolares de comunas vulnerables, Región MetropolitanaFiltrado glomerular, método preventivo aparición de fibrosis sistémica nefrogénica por gadolinio en examen de RMImplementación de consejerías en vida sana en APS, Región de los RíosMedicina preventiva en feria libre de la población San Gregorio: Cecof San Gregorio, Contagiando SaludMetodología innovadora en la enseñanza de una ectoparasitosisPrevención de accidentes por monóxido de carbono en edificios, Providencia 2002-2009Programa de promoción y prevención en salud bucal para preescolaresPromoviendo hábitos saludables en los vecinos de Reñaca Alto, Viña del Mar, 2009Rol de la capacitación en la implementación de acciones para la prevención de la obesidadSatisfacción usuaria en el Cesfam Natales a un año de su funcionamientoTres estrategias publicitarias y de comunicación aplicadas al consumo de alcohol de bajo riesgoTropa de la salud: uso de los medios como forma de promover la salu

Thermal and lighting perception in four fully glazed office buildings in Santiago, Chile

Corresponding author: Claudio Vásquez, School of Architecture, Catholic University of Chile. 1916 El Comendador str. Providencia, Santiago, ZIP: 7530091, Chile. Tel.: +56 9 92826305; E-mail: [email protected] This paper is part of a general research project whose main objective is to establish a baseline for post-occupancy energy consumption and indoor environmental quality for office buildings in Santiago, Chile. This study aims at understanding how architectonical variables relate to, and can even determine, user comfort perception. Thus, one-year continuous monitoring in several floors at four office buildings was performed and seasonal surveys were completed. Survey participants were asked a series of questions regarding spatial orientation and comfort perception in their workspace. The data from the comfort survey and onsite measurements such as season of the year, case study, type of workspace and possibility of an outdoor view from the workstation were contrasted with the components obtained by a Principal Component Analysis (PCA). Three components were selected from the PCA, and three Maps of Perception (MP) were produced. These maps were then analyzed and interpreted so as to obtain information on the general perception of thermal and lighting comfort at workspaces within several office buildings in Santiago

Thermal and lighting perception in four fully glazed office buildings in Santiago, Chile

This paper is part of a general research project whose main objective is to establish a baseline for post-occupancy energy consumption and indoor environmental quality for office buildings in Santiago, Chile. This study aims at understanding how architectonical variables relate to, and can even determine, user comfort perception.  Thus, one-year continuous monitoring in several floors at four office buildings was performed and seasonal surveys were completed.  Survey participants were asked a series of questions regarding spatial orientation and comfort perception in their workspace. The data from the comfort survey and onsite measurements such as season of the year, case study, type of workspace and possibility of an outdoor view from the workstation were contrasted with the components obtained by a Principal Component Analysis (PCA). Three components were selected from the PCA, and three Maps of Perception (MP) were produced. These maps were then analyzed and interpreted so as to obtain information on the general perception of thermal and lighting comfort at workspaces within several office buildings in Santiago

Thermal and lighting perception in four fully glazed office buildings in Santiago, Chile

This paper is part of a general research project whose main objective is to establish a baseline for post-occupancy energy consumption and indoor environmental quality for office buildings in Santiago, Chile. This study aims at understanding how architectonical variables relate to, and can even determine, user comfort perception.  Thus, one-year continuous monitoring in several floors at four office buildings was performed and seasonal surveys were completed.  Survey participants were asked a series of questions regarding spatial orientation and comfort perception in their workspace.The data from the comfort survey and onsite measurements such as season of the year, case study, type of workspace and possibility of an outdoor view from the workstation were contrasted with the components obtained by a Principal Component Analysis (PCA). Three components were selected from the PCA, and three Maps of Perception (MP) were produced. These maps were then analyzed and interpreted so as to obtain information on the general perception of thermal and lighting comfort at workspaces within several office buildings in Santiago

Diseño y desarrollo de una herramienta audiovisual para la docencia virtual de la inspección veterinaria oficial de pescados y productos de la pesca en un mercado central

El objetivo global de este Proyecto de Innovación Docente es la creación de vídeos explicativos como una herramienta de aprendizaje incorporada en el Campus Virtual para mejorar el estudio sobre las actividades de higiene, inspección y control alimentario que se realizan en el Mercado Central de Pescados de Mercamadrid. La creación y el empleo de estos vídeos están dirigidos, en un principio, a los estudiantes universitarios de Grado en Veterinaria que cursan la asignatura de Higiene, Inspección y Seguridad Alimentaria. En este Proyecto se han creado vídeos explicativos que tratan sobre: (i) los controles oficiales realizados por los Técnicos Superiores Veterinarios de Mercamadrid; (ii) los riesgos sanitarios asociados al consumo de pescados, crustáceos y moluscos; (iii) la frescura del pescado; (iv) el etiquetado del pescado; (v) la identificación de especies de pescado y marisco; (vi) la prevención de fraudes en la comercialización de pescados y mariscos; y (vii) la autentificación de pescados fileteados mediante técnicas de análisis

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trialResearch in context

Summary: Background: Anti-COVID-19 hyperimmune immunoglobulin (hIG) can provide standardized and controlled antibody content. Data from controlled clinical trials using hIG for the prevention or treatment of COVID-19 outpatients have not been reported. We assessed the safety and efficacy of subcutaneous anti-COVID-19 hyperimmune immunoglobulin 20% (C19-IG20%) compared to placebo in preventing development of symptomatic COVID-19 in asymptomatic individuals with SARS-CoV-2 infection. Methods: We did a multicentre, randomized, double-blind, placebo-controlled trial, in asymptomatic unvaccinated adults (≥18 years of age) with confirmed SARS-CoV-2 infection within 5 days between April 28 and December 27, 2021. Participants were randomly assigned (1:1:1) to receive a blinded subcutaneous infusion of 10 mL with 1 g or 2 g of C19-IG20%, or an equivalent volume of saline as placebo. The primary endpoint was the proportion of participants who remained asymptomatic through day 14 after infusion. Secondary endpoints included the proportion of individuals who required oxygen supplementation, any medically attended visit, hospitalisation, or ICU, and viral load reduction and viral clearance in nasopharyngeal swabs. Safety was assessed as the proportion of patients with adverse events. The trial was terminated early due to a lack of potential benefit in the target population in a planned interim analysis conducted in December 2021. ClinicalTrials.gov registry: NCT04847141. Findings: 461 individuals (mean age 39.6 years [SD 12.8]) were randomized and received the intervention within a mean of 3.1 (SD 1.27) days from a positive SARS-CoV-2 test. In the prespecified modified intention-to-treat analysis that included only participants who received a subcutaneous infusion, the primary outcome occurred in 59.9% (91/152) of participants receiving 1 g C19-IG20%, 64.7% (99/153) receiving 2 g, and 63.5% (99/156) receiving placebo (difference in proportions 1 g C19-IG20% vs. placebo, −3.6%; 95% CI -14.6% to 7.3%, p = 0.53; 2 g C19-IG20% vs placebo, 1.1%; −9.6% to 11.9%, p = 0.85). None of the secondary clinical efficacy endpoints or virological endpoints were significantly different between study groups. Adverse event rate was similar between groups, and no severe or life-threatening adverse events related to investigational product infusion were reported. Interpretation: Our findings suggested that administration of subcutaneous human hyperimmune immunoglobulin C19-IG20% to asymptomatic individuals with SARS-CoV-2 infection was safe but did not prevent development of symptomatic COVID-19. Funding: Grifols

BJS commission on surgery and perioperative care post-COVID-19

Background: Coronavirus disease 2019 (COVID-19) was declared a pandemic by the WHO on 11 March 2020 and global surgical practice was compromised. This Commission aimed to document and reflect on the changes seen in the surgical environment during the pandemic, by reviewing colleagues experiences and published evidence. Methods: In late 2020, BJS contacted colleagues across the global surgical community and asked them to describe how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had affected their practice. In addition to this, the Commission undertook a literature review on the impact of COVID-19 on surgery and perioperative care. A thematic analysis was performed to identify the issues most frequently encountered by the correspondents, as well as the solutions and ideas suggested to address them. Results: BJS received communications for this Commission from leading clinicians and academics across a variety of surgical specialties in every inhabited continent. The responses from all over the world provided insights into multiple facets of surgical practice from a governmental level to individual clinical practice and training. Conclusion: The COVID-19 pandemic has uncovered a variety of problems in healthcare systems, including negative impacts on surgical practice. Global surgical multidisciplinary teams are working collaboratively to address research questions about the future of surgery in the post-COVID-19 era. The COVID-19 pandemic is severely damaging surgical training. The establishment of a multidisciplinary ethics committee should be encouraged at all surgical oncology centres. Innovative leadership and collaboration is vital in the post-COVID-19 era